ReposiTrak Inc. (NYSE:TRAK - Get Free Report) CEO Randall K. Fields sold 2,500 shares of the firm's stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $20.05, for a total value of $50,125.00. Following the sale, the chief executive officer now directly owns 167,000 shares of the company's stock, valued at $3,348,350. This trade represents a 1.47% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
ReposiTrak Stock Up 0.6%
Shares of TRAK traded up $0.12 during midday trading on Friday, reaching $19.94. 94,109 shares of the stock were exchanged, compared to its average volume of 46,046. ReposiTrak Inc. has a 12-month low of $14.83 and a 12-month high of $25.01. The company has a debt-to-equity ratio of 0.01, a current ratio of 6.03 and a quick ratio of 6.03. The company has a market capitalization of $364.42 million, a PE ratio of 58.65 and a beta of 0.54.
ReposiTrak Cuts Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 14th. Stockholders of record on Monday, June 30th will be paid a dividend of $0.0182 per share. This represents a $0.07 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend is Monday, June 30th. ReposiTrak's dividend payout ratio (DPR) is presently 20.59%.
Institutional Investors Weigh In On ReposiTrak
An institutional investor recently raised its position in ReposiTrak stock. Ellsworth Advisors LLC raised its position in shares of ReposiTrak Inc. (NYSE:TRAK - Free Report) by 10.6% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,289 shares of the company's stock after purchasing an additional 2,997 shares during the period. Ellsworth Advisors LLC owned 0.17% of ReposiTrak worth $634,000 as of its most recent SEC filing. 27.35% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen raised ReposiTrak from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.
View Our Latest Research Report on TRAK
ReposiTrak Company Profile
(
Get Free Report)
Park City Group, Inc, a software-as-a-service provider, designs, develops, and markets proprietary software products in North America. The company offers ReposiTrak MarketPlace, a supplier discovery and B2B e-commerce solution; ReposiTrak Compliance and Food Safety solutions, which reduces potential regulatory and legal risk from their supply chain partners; and ReposiTrak Supply Chain solutions that enables customers to manage relationships with suppliers.
Featured Articles

Before you consider ReposiTrak, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReposiTrak wasn't on the list.
While ReposiTrak currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.